New drug targets Hard-to-Treat cancer mutation in early trial
NCT ID NCT06619587
First seen Jun 24, 2026 · Last updated Jul 29, 2026 · Updated 5 times
Summary
This study tests a new drug called GDC-7035, designed to target cancers with a specific genetic change called KRAS G12D. The trial includes about 410 adults with advanced solid tumors that have not responded to other treatments. Researchers will give the drug alone or with other cancer therapies to check its safety and how well it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GDC-7035 (a drug targeting the KRAS G12D mutation)
- What this could lead to
- If successful, this could lead to a new targeted treatment option for people with advanced solid tumors that have a specific KRAS G12D mutation.
- What could go wrong
- This is a very early (first-in-human) study, so safety and effectiveness are not yet known. Many early-stage cancer drugs do not end up working in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abramson Cancer Center;Univ of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104-5127, United States
-
Asan Medical Center.
RECRUITINGSeoul, 005505, South Korea
-
British Columbia Cancer Agency
RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
-
Centre Georges Francois Leclerc
RECRUITINGDijon, 21000, France
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Florida Cancer Specialist-Lake Mary
COMPLETEDLake Mary, Florida, 32746, United States
-
Gustave Roussy
RECRUITINGVillejuif, Val-de-Marne, 94805, France
-
Hadassah University Hospital - Ein Kerem
RECRUITINGJerusalem, 9112001, Israel
-
Hospital Clinico Universitario de Valencia
RECRUITINGValencia, 46010, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario Virgen de la Victoria
RECRUITINGMálaga, 29010, Spain
-
Hospital Universitario Virgen del Rocio - PPDS
RECRUITINGSeville, 41013, Spain
-
Institut Bergonie
RECRUITINGBordeaux, 33076, France
-
Instituto de Investigacion Oncologica Vall dHebron (VHIO) - EPON
RECRUITINGBarcelona, 08035, Spain
-
Mary Crowley Medical Research Center
RECRUITINGDallas, Pennsylvania, 75230-2571, United States
-
Montefiore Einstein Cancer Center
RECRUITINGThe Bronx, New York, 10461, United States
-
NIHR UCLH Clinical Research Facility
RECRUITINGLondon, W1T 7HA, United Kingdom
-
National Cancer Centre
RECRUITINGSingapore, 168583, Singapore
-
National University Hospital
RECRUITINGSingapore, 119074, Singapore
-
O'Quinn Medical Tower at McNair Campus
RECRUITINGHouston, Texas, 77054, United States
-
Peter Maccallum Cancer Centre
RECRUITINGParkville, Victoria, 3052, Australia
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 1X6, Canada
-
Rambam Health Care Campus
RECRUITINGHaifa, 3109601, Israel
-
Royal Marsden Hospital - Surrey
RECRUITINGSutton, SM2 5PT, United Kingdom
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
START - Midwest - EDOS
RECRUITINGGrand Rapids, Michigan, 49546-7062, United States
-
START Madrid_Hospital Universitario HM Sanchinarro_CIOCC
RECRUITINGMadrid, 28050, Spain
-
Sarah Cannon Research Institute at HealthONE
RECRUITINGDenver, Colorado, 80218, United States
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam, 13620, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 3722, South Korea
-
Sir Mortimer B Davis Jewish General Hospital
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
-
Slade Health Inward goods
RECRUITINGMount Kuring-Gai, New South Wales, 2080, Australia
-
St Vincent's Hospital Sydney
RECRUITINGDarlinghurst, New South Wales, 2010, Australia
-
Tel Aviv Sourasky Medical Center PPDS
RECRUITINGTel Aviv, 6423906, Israel
-
The Chaim Sheba Medical Center
RECRUITINGRamat Gan, 5262100, Israel
-
The Christie
RECRUITINGManchester, M20 4BX, United Kingdom
-
UC San Diego Moores Cancer Center
RECRUITINGLa Jolla, California, 92093-1503, United States
-
University of Illinois
RECRUITINGChicago, Illinois, 60612, United States
-
Western General Hospital;Edinburgh Cancer Center
RECRUITINGEdinburgh, Midlothian, EH4 2LF, United Kingdom
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a Tumor's DNA guide better cancer care for kids?
- Can a new PET tracer reveal a key cancer target?
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a new tracer light up cancer growth?
- Can a Dual-Pronged antibody outsmart advanced cancers?